Unraveling the stability landscape of mutations in the SARS-CoV-2 receptor-binding domain
Abstract The interaction between the receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein and the ACE2 enzyme is believed to be the entry point of the virus into various cells in the body, including the lungs, heart, liver, and kidneys. The current focus of several therapeutic design e...
Guardado en:
Autores principales: | Mohamed Raef Smaoui, Hamdi Yahyaoui |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b8913412ea3042efbb8a5bc3b430b8df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Xiaojing Chi, et al.
Publicado: (2020) -
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
por: Timothy J. C. Tan, et al.
Publicado: (2021) -
An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines
por: Yan Guo, et al.
Publicado: (2021) -
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
por: Yuan Yuan, et al.
Publicado: (2017) -
Molecular strategies for antibody binding and escape of SARS-CoV-2 and its mutations
por: Mohamed Hendy, et al.
Publicado: (2021)